Derek Archila

Apr 09, 2026

NRIX received a Overweight rating from Derek Archila on Apr 09, 2026, aiming for 28. Momentum has favored the Buy call, with shares climbing from 17.51 to 17.51, rewarding those who trusted the recommendation.

Mar 19, 2026

Derek Archila on Mar 19, 2026 assigned ALXO a Overweight rating, with a price target of 5. The call has struggled to gain traction, with shares losing 23.74%.

Mar 18, 2026

On Mar 18, 2026, Derek Archila reaffirmed GLUE with a Overweight rating, targeting 29. The recommendation was supported by strong follow-through as the stock rose from 19.78 to 19.78.

Mar 12, 2026

RYTM was rated Overweight by Derek Archila on Mar 12, 2026, with a price objective of 143. The stock is in a wait-and-see zone, leaving the Buy case open-ended.

Mar 03, 2026

On Mar 03, 2026, Derek Archila initiated coverage on SEPN with a Overweight rating and target of 48. The Buy call has yet to be validated as shares remain 21.87 away from the target.

Mar 02, 2026

Derek Archila issued a Overweight recommendation for IRON on Mar 02, 2026, price target set at 79. Investors following the Buy call captured upside momentum, with shares now at 71.77.

Feb 27, 2026

On Feb 27, 2026, ARGX was evaluated by Derek Archila, who gave a Overweight rating and target of 1.32. This case illustrates how a timely bullish rating can translate into tangible gains of 10.71%.

Feb 13, 2026

Derek Archila rated BBIO as Overweight on Feb 13, 2026, setting a price target of 98. Shares have remained stable near 76.75, leaving the 98 target still in play.

Jan 20, 2026

On Jan 20, 2026, Derek Archila published a Overweight outlook on ASND, with a target of 330. Shares gained 13.41%, underscoring the accuracy of the bullish outlook toward 330.

Jan 06, 2026

On Jan 06, 2026, Derek Archila reaffirmed ALMS with a Overweight rating, targeting 39. The recommendation was supported by strong follow-through as the stock rose from 24.99 to 24.99.

Dec 16, 2025

KYTX was rated Overweight by Derek Archila on Dec 16, 2025, with a price objective of 33. The stock is in a wait-and-see zone, leaving the Buy case open-ended.

Dec 09, 2025

On Dec 09, 2025, Derek Archila initiated coverage on KYMR with a Overweight rating and target of 116. Neutral price movement of 0.96% leaves room for interpretation.

Dec 08, 2025

Derek Archila issued a Overweight recommendation for ORIC on Dec 08, 2025, price target set at 25. The target of 25 remains in play, though confirmation will depend on future moves.

Nov 19, 2025

On Nov 19, 2025, ANNX was evaluated by Derek Archila, who gave a Overweight rating and target of 27. This case illustrates how a timely bullish rating can translate into tangible gains of 61.08%.

Nov 06, 2025

Derek Archila rated ARVN as Overweight on Nov 06, 2025, setting a price target of 15. The call has proven timely, with shares rising 10.00% toward the price target of 15.

Nov 05, 2025

On Nov 05, 2025, ANAB was given a Overweight rating by Derek Archila, with a target price of 81. The stock rallied 87.53% after the rating, narrowing the gap to the target of 81 and validating the bullish stance.

Sep 23, 2025

Derek Archila on Sep 23, 2025 assigned CCCC a Overweight rating, with a price target of 10. The Buy call aligned well with market performance, producing a gain of 12.74%.

Aug 20, 2025

CLDX was rated Overweight by Derek Archila on Aug 20, 2025, with a price objective of 38. A bullish response from the market helped close the gap of 3.45 to the target.

Dec 19, 2024

IMVT received a Overweight rating from Derek Archila on Dec 19, 2024, aiming for 45. Momentum has favored the Buy call, with shares climbing from 29.3 to 29.3, rewarding those who trusted the recommendation.

Dec 11, 2024

Derek Archila on Dec 11, 2024 assigned SLRN a Overweight rating, with a price target of 13. The call has struggled to gain traction, with shares losing 33.43%.